Purdue Pharma Reaches $8B Opioid Deal With Justice Department Over Oxycontin Sales

Critics say the settlement doesn't hold company executives or members of the Sackler family accountable for their aggressive marketing of Oxycontin which helped fuel the nation's opioid epidemic.